Guy Mollett
Impact in
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Modeling and Simulation top 5%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 11
- COVID-19 Clinical Research Studies 3
- Infection Control in Healthcare 1
- Antifungal resistance and susceptibility 1
-
- Actinomycetales infections and treatment 1
- Co-authors
- David L. Robertson (1 shared paper)Massimo Palmarini (1 shared paper)Pablo R. Murcia (1 shared paper)John Haughney (1 shared paper)Richard J Orton (1 shared paper)Thomas P. Peacock (1 shared paper)Brian J. Willett (1 shared paper)William Barclay (1 shared paper)
- Journals
- Nature Communications (2 papers)Nature (2 papers)Journal of Infection (2 papers)Mycoses (1 paper)Clinical Infectious Diseases (1 paper)
- Partner nations
- United KingdomIndiaBelgium
In The Last Decade
Guy Mollett
15 papers receiving 2.2k citations
Guy Mollett's Hit Papers
Peers
Comparison fields: 5 of 85
- Infectious Diseases 1.9k
- Modeling and Simulation 92
- Microbiology 4
- Public Health, Environmental and Occupational Health 91
- Neurology 26
Countries citing papers authored by Guy Mollett
This map shows the geographic impact of Guy Mollett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Mollett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Mollett more than expected).
Fields of papers citing papers by Guy Mollett
This network shows the impact of papers produced by Guy Mollett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Mollett. The network helps show where Guy Mollett may publish in the future.
Co-authors
The 25 scholars most cited alongside Guy Mollett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 evolution during treatment of chronic infection Hit paper breakdown → | 2021 | 814 |
| 2 | Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies Hit paper breakdown → | 2021 | 530 |
| 3 | Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7 Hit paper breakdown → | 2021 | 325 |
| 4 | 2021 | 228 | |
| 5 | 2021 | 144 | |
| 6 | 2020 | 43 | |
| 7 | 2022 | 31 | |
| 8 | 2021 | 25 | |
| 9 | 2018 | 22 | |
| 10 | 2023 | 19 | |
| 11 | 2022 | 13 | |
| 12 | 2021 | 10 | |
| 13 | 2023 | 10 | |
| 14 | 2023 | 7 | |
| 15 | 2021 | 3 |
About Guy Mollett
Guy Mollett is a scholar working on Infectious Diseases, Microbiology, Modeling and Simulation, Public Health, Environmental and Occupational Health and Nuclear Energy and Engineering, having authored 15 papers that have together received 2.2k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (11 papers), COVID-19 Clinical Research Studies (3 papers), Research on Leishmaniasis Studies (2 papers), Actinomycetales infections and treatment (1 paper), Infection Control in Healthcare (1 paper), Antifungal resistance and susceptibility (1 paper) and COVID-19 epidemiological studies (1 paper). The work is most often cited by research in Infectious Diseases (1.9k citations), Modeling and Simulation (92 citations), Microbiology (4 citations), Public Health, Environmental and Occupational Health (91 citations) and Neurology (26 citations). Guy Mollett has collaborated with scholars based in United Kingdom, India and Belgium. Frequent co-authors include David L. Robertson, Massimo Palmarini, Pablo R. Murcia, John Haughney, Richard J Orton, Thomas P. Peacock, Brian J. Willett, William Barclay, Arvind H. Patel and Rachel Blacow. Their work appears in journals such as Nature Communications, Nature, Journal of Infection, Mycoses and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.